CIRCAdian Rhythm of the IMMune Age IndeX (IMMAX)

NCT07169721 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2025-09-17

No results posted yet for this study

Summary

The goal of this observational study is to evaluate the influence of circadian rhythms on the determination of an individual's immune age. The biomarker IMMAX was calculated for 50 participants aged 20-69 at 8 a.m., 1 p.m. and 6 p.m. on the same day.

Conditions

  • Healthy Subjects
  • Immune Cells (Mucosal and Systemic)

Sponsors & Collaborators

  • Leibniz Research Centre for Working Environment and Human Factors

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-12-01
Primary Completion
2024-03-28
Completion
2024-04-22

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07169721 on ClinicalTrials.gov